Internal Medicine, Hematology & Oncology · Bayamon, PR
NPI
1952412918
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
100 Paseo San Pablo, Edif Arturo Cadilla Suite 510
Bayamon, PR, 00961
Phone (787) 780-2830
Groups this clinician bills Medicare through
Medicare paid, 2024
$91K
10,333 services
Medicare patients, 2024
53
Average age 78
Drug cost, 2024
$4.8M
1,603 prescriptions
Company payments, 2025
$6,017
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yelitza Ruiz was code 99214 (office e&m - established), 88 times for 45 patients. In total Yelitza Ruiz billed 10,333 services in 30 codes, and Medicare paid $91K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 88 | 45 | $96.60 | $8,501 |
By year: 2022 $7,459 for 170 services; 2023 $30K for 1,344 services; 2024 $91K for 10,333 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yelitza Ruiz prescribed most often to Medicare patients was Anastrozole, with 313 prescriptions and refills. In total Yelitza Ruiz wrote 1,603 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 313 | 465 | 62 | $6,487 |
| Letrozole Generic | 103 | 111 | 17 | $1,431 |
| Prednisone Generic | 99 | 99 | 12 | $562 |
| Ibrance Palbociclib | 89 | 89 | 12 | $1.4M |
| Exemestane Generic | 62 | 88 | 13 | $6,795 |
| Hydroxyurea Generic | 51 | 57 | Under 11 | $1,307 |
| Abiraterone Acetate Generic | 48 | 48 | Under 11 | $40K |
| Warfarin Sodium Generic | 44 | 106 | Under 11 | $440 |
| Revlimid Lenalidomide | 38 | 38 | Under 11 | $810K |
| Ondansetron Hcl Generic | 28 | 28 | 16 | $175 |
| Raloxifene Hcl Generic | 27 | 35 | Under 11 | $898 |
| Tagrisso Osimertinib Mesylate | 24 | 24 | Under 11 | $396K |
| Alendronate Sodium Generic | 22 | 27 | Under 11 | $116 |
| Lynparza Olaparib | 21 | 21 | Under 11 | $355K |
| Famotidine Generic | 20 | 22 | Under 11 | $103 |
Brand drugs: 403 claims; generic drugs: 1,200 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yelitza Ruiz $6,017 ($6,017 in general payments such as food, travel and fees) from 34 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $696.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 31 | $696 |
| Janssen Pharmaceuticals, Inc JNJ | 25 | $575 |
| Abbvie Inc. ABBV | 20 | $544 |
| Genentech USA, Inc. ROG.SW | 20 | $400 |
| Pbg Puerto Rico LLC | 19 | $370 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $341 |
| Merck Sharp & Dohme LLC MRK | 15 | $328 |
| Tempus AI, Inc TEM | 14 | $310 |
| Amgen Inc. AMGN | 15 | $285 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $230 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.